Trent J - Search Results

1

Patient-reported outcomes and tolerability in patients receiving ripretinib versus sunitinib after treatment with imatinib in INTRIGUE, a phase 3, open-label study.

Gelderblom H, Jones RL, Blay JY, George S, von Mehren M, Zalcberg JR, Kang YK, Razak AA, Trent J, Attia S, Le Cesne A, Siontis BL, Goldstein D, Boye K, Sanchez C, Steeghs N, Rutkowski P, Druta M, Serrano C, Somaiah N, Chi P, Harrow B, Becker C, Reichmann W, Sherman ML, Ruiz-Soto R, Heinrich MC, Bauer S; INTRIGUE investigators. Gelderblom H, et al. Among authors: trent j. Eur J Cancer. 2023 Oct;192:113245. doi: 10.1016/j.ejca.2023.113245. Epub 2023 Jul 20. Eur J Cancer. 2023. PMID: 37598656 Free article. Clinical Trial.

2

A two-arm phase II study of temozolomide in patients with advanced gastrointestinal stromal tumors and other soft tissue sarcomas.

Trent JC, Beach J, Burgess MA, Papadopolous N, Chen LL, Benjamin RS, Patel SR. Trent JC, et al. Cancer. 2003 Dec 15;98(12):2693-9. doi: 10.1002/cncr.11875. Cancer. 2003. PMID: 14669291 Free article. Clinical Trial.

3

Expression of Bcl-2 in gastrointestinal stromal tumors: correlation with progression-free survival in 81 patients treated with imatinib mesylate.

Steinert DM, Oyarzo M, Wang X, Choi H, Thall PF, Medeiros LJ, Raymond AK, Benjamin RS, Zhang W, Trent JC. Steinert DM, et al. Cancer. 2006 Apr 1;106(7):1617-23. doi: 10.1002/cncr.21781. Cancer. 2006. PMID: 16518826 Free article.

4

Rare incidence of congestive heart failure in gastrointestinal stromal tumor and other sarcoma patients receiving imatinib mesylate.

Trent JC, Patel SS, Zhang J, Araujo DM, Plana JC, Lenihan DJ, Fan D, Patel SR, Benjamin RS, Khakoo AY. Trent JC, et al. Cancer. 2010 Jan 1;116(1):184-92. doi: 10.1002/cncr.24683. Cancer. 2010. PMID: 19885836 Free PMC article.

5

The role of high-dose imatinib in the management of patients with gastrointestinal stromal tumor.

Gronchi A, Blay JY, Trent JC. Gronchi A, et al. Cancer. 2010 Apr 15;116(8):1847-58. doi: 10.1002/cncr.24944. Cancer. 2010. PMID: 20166214 Free article. Review.

6

NCCN Task Force report: update on the management of patients with gastrointestinal stromal tumors.

Demetri GD, von Mehren M, Antonescu CR, DeMatteo RP, Ganjoo KN, Maki RG, Pisters PW, Raut CP, Riedel RF, Schuetze S, Sundar HM, Trent JC, Wayne JD. Demetri GD, et al. J Natl Compr Canc Netw. 2010 Apr;8 Suppl 2(0 2):S1-41; quiz S42-4. doi: 10.6004/jnccn.2010.0116. J Natl Compr Canc Netw. 2010. PMID: 20457867 Free PMC article.

7

Personalized cancer therapy for gastrointestinal stromal tumor: synergizing tumor genotyping with imatinib plasma levels.

Marrari A, Trent JC, George S. Marrari A, et al. Curr Opin Oncol. 2010 Jul;22(4):336-41. doi: 10.1097/CCO.0b013e32833a6b8e. Curr Opin Oncol. 2010. PMID: 20489620 Review.

8

The role of imatinib plasma level testing in gastrointestinal stromal tumor.

George S, Trent JC. George S, et al. Cancer Chemother Pharmacol. 2011 Jan;67 Suppl 1:S45-50. doi: 10.1007/s00280-010-1527-2. Epub 2010 Dec 8. Cancer Chemother Pharmacol. 2011. PMID: 21140148 Review.

9

Mechanisms of resistance to imatinib and sunitinib in gastrointestinal stromal tumor.

Wang WL, Conley A, Reynoso D, Nolden L, Lazar AJ, George S, Trent JC. Wang WL, et al. Among authors: trent jc. Cancer Chemother Pharmacol. 2011 Jan;67 Suppl 1:S15-24. doi: 10.1007/s00280-010-1513-8. Epub 2010 Dec 24. Cancer Chemother Pharmacol. 2011. PMID: 21181476 Review.

10

An unusual site of metastasis from gastrointestinal stromal tumor.

Cauchi C, Trent JC, Edwards K, Davey M, Lopez M, Yu JQ, von Mehren M. Cauchi C, et al. Rare Tumors. 2010 Dec 31;2(4):e58. doi: 10.4081/rt.2010.e58. Rare Tumors. 2010. PMID: 21234250 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

965 results

Search Page